Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Total Stockholders' Equity	Common Stock	Additional Paid-In Capital	Distributions in Excess of Cumulative Earnings	Accumulated Other Comprehensive Income (Loss)	Non- Controlling Interests
Balance at beginning of period (in shares) at Dec. 31, 2020			106,361,524
Balance at beginning of period at Dec. 31, 2020	$ 1,581,948	$ 1,574,758	$ 1,064	$ 1,688,540	$ (77,665)	$ (37,181)	$ 7,190
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issuance (in shares)			18,230,721
Common stock issuance	469,200	469,200	$ 182	469,018			0
Common stock withheld related to net share settlement of equity awards	(353)	(353)			(353)
Costs related to issuance of common stock	(12,153)	(12,153)		(12,153)
Other comprehensive income (loss)	22,508	22,395				22,395	113
Equity based compensation expense (in shares)			56,808
Equity based compensation expense	5,683	5,683	$ 0	5,683
Dividends declared on common stock and OP Units	(119,241)	(118,689)			(118,689)		(552)
Net income	96,211	95,725			95,725		486
Balance at end of period (in shares) at Dec. 31, 2021			124,649,053
Balance at end of period at Dec. 31, 2021	2,043,803	2,036,566	$ 1,246	2,151,088	(100,982)	(14,786)	7,237
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issuance (in shares)			17,576,684
Common stock issuance	413,845	413,845	$ 178	413,667
Common stock withheld related to net share settlement of equity awards	(2,452)	(2,452)			(2,452)
Costs related to issuance of common stock	(10,939)	(10,939)		(10,939)
Other comprehensive income (loss)	56,762	55,505				55,505	1,257
Equity based compensation expense (in shares)			153,918
Equity based compensation expense	9,489	9,489		9,489
Dividends declared on common stock and OP Units	(148,479)	(147,883)			(147,883)		(596)
Net income	$ 134,742	134,130			134,130		612
Balance at end of period (in shares) at Dec. 31, 2022	142,379,655		142,379,655
Balance at end of period at Dec. 31, 2022	$ 2,496,771	2,488,261	$ 1,424	2,563,305	(117,187)	40,719	8,510
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issuance (in shares)			21,971,744
Common stock issuance	507,380	507,380	$ 219	507,161
Common stock withheld related to net share settlement of equity awards	(3,671)	(3,671)			(3,671)
Costs related to issuance of common stock	(1,010)	(1,010)		(1,010)
Other comprehensive income (loss)	(36,874)	(36,700)				(36,700)	(174)
Equity based compensation expense (in shares)			283,751
Equity based compensation expense	9,006	9,006	$ 3	9,003
Dividends declared on common stock and OP Units	(176,015)	(175,394)			(175,394)		(621)
Net income	$ 191,415	190,707			190,707		708
Balance at end of period (in shares) at Dec. 31, 2023	164,635,150		164,635,150
Balance at end of period at Dec. 31, 2023	$ 2,987,002	$ 2,978,579	$ 1,646	$ 3,078,459	$ (105,545)	$ 4,019	$ 8,423